MIM
REPL icon

MetLife Investment Management’s Replimune Group REPL Stock Holding History

MetLife Investment Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
38,355
+4,027
+12% +$30.8K ﹤0.01% 2014
2025
Q4 		$334K Sell
34,328
-6,210
-15% -$52.8K ﹤0.01% 1999
2025
Q3 		$170K Sell
40,538
-60
-0.1% -$383 ﹤0.01% 2407
2025
Q2 		$377K Hold
40,598
– – ﹤0.01% 1813
2025
Q1 		$396K Buy
40,598
+2,939
+8% +$36.4K ﹤0.01% 1834
2024
Q4 		$456K Buy
37,659
+2,525
+7% +$30.7K ﹤0.01% 1852
2024
Q3 		$385K Buy
35,134
+6,216
+21% +$63.1K ﹤0.01% 1921
2024
Q2 		$260K Buy
28,918
+2,273
+9% +$15.8K ﹤0.01% 2082
2024
Q1 		$218K Hold
26,645
– – ﹤0.01% 2160
2023
Q4 		$225K Buy
26,645
+5,140
+24% +$59.6K ﹤0.01% 2176
2023
Q3 		$368K Hold
21,505
– – ﹤0.01% 1814
2023
Q2 		$499K Sell
21,505
-3,069
-12% -$60K ﹤0.01% 1691
2023
Q1 		$434K Buy
24,574
+2,948
+14% +$70.1K ﹤0.01% 1729
2022
Q4 		$588K Hold
21,626
– – ﹤0.01% 1533
2022
Q3 		$373K Buy
21,626
+6,417
+42% +$122K ﹤0.01% 1850
2022
Q2 		$266K Hold
15,209
– – ﹤0.01% 2110
2022
Q1 		$258K Buy
15,209
+5,344
+54% +$101K ﹤0.01% 2190
2021
Q4 		$267K Hold
9,865
– – ﹤0.01% 1876
2021
Q3 		$292K Hold
9,865
– – ﹤0.01% 1835
2021
Q2 		$379K Hold
9,865
– – ﹤0.01% 1740
2021
Q1 		$301K Hold
9,865
– – ﹤0.01% 1810
2020
Q4 		$376K Hold
9,865
– – ﹤0.01% 1620
2020
Q3 		$227K Hold
9,865
– – ﹤0.01% 1794
2020
Q2 		$245K Buy
+9,865
New +$174K ﹤0.01% 1781

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MetLife Investment Management's REPL Position: Q1 2026 in Review

MetLife Investment Management increased its Replimune Group (REPL) stake by 12% in Q1 2026, buying an estimated $30.8K and bringing the position to 38,355 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

MetLife Investment Management first reported a position in REPL in Q2 2020 and has held it in 24 quarters since. The position peaked at $588K in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • MetLife Investment Management held 38,355 shares of Replimune Group worth $293K as of Q1 2026.
  • MetLife Investment Management bought 4,027 Replimune Group shares in Q1 2026, an estimated $30.8K.
  • Replimune Group made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2014 holding.
  • MetLife Investment Management first reported a position in Replimune Group in Q2 2020 and has held it in 24 quarters since.
  • MetLife Investment Management's Replimune Group position peaked at $588K in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.